Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US5324571083
Ticker LLY.F
Company ELI LILLY
Currency $
Price
Aware Investor Index (AII) 10.4872
Recommendation STRONG BUY
P/E 30.46
ROE 30.33 %
Capitalization 100,782,532,500 $
Dividend Yield 2.39 %
P/S 4.10
AII Position 111
P/E Position 446
ROE Position 92
Capitalization Position 90
Dividend Yield Position 322
Sales 24,555,700,000 $
10-Year Average Earnings 3,308,380,000 $
Shares Outstanding 1,033,667,000
Equity 10,909,100,000 $
Dividend per Share 2.33 $
Industry Pharmaceutical
Country United States
ELI LILLY Investor Relations Web Site http://investor.lilly.com/







Sales:

YEAR MONTH AMOUNT
2018 12 24,555,700,000.00 $
2017 12 22,871,300,000.00 $
2016 12 21,222,100,000.00 $
2015 12 19,958,700,000.00 $
2014 12 19,615,600,000.00 $
2013 12 23,113,100,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 3,232,000,000.00 $
2017 12 -204,100,000.00 $
2016 12 2,737,600,000.00 $
2015 12 2,408,400,000.00 $
2014 12 2,390,500,000.00 $
2013 12 4,684,800,000.00 $
2012 12 4,088,600,000.00 $
2011 12 4,347,700,000.00 $
2010 12 5,069,500,000.00 $
2009 12 4,328,800,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 10,909,100,000.00 $
2017 12 11,667,900,000.00 $
2016 12 14,080,500,000.00 $
2015 12 14,590,300,000.00 $
2014 12 15,388,100,000.00 $
2013 12 17,640,700,000.00 $
2012 12 14,773,900,000.00 $
2011 12 13,535,600,000.00 $
2010 12 12,412,800,000.00 $
2009 12 9,525,300,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,033,667,000
2017 12 1,052,023,000
2016 12 1,061,825,000
2015 12 1,065,720,000
2014 12 1,074,286,000
2013 12 1,084,766,000
2012 12 1,134,411,762
2011 12 1,113,967,000
2010 12 1,105,813,000
2009 12 1,098,367,000

 












Bloomberg News for ELI LILLY:



Google News for ELI LILLY:



Back